“We have seen remarkable results from clinical trials using AAV vectors for AADC gene transfer,” says Shin-ichi Muramatsu, a pioneer of AAV vector research, and a professor in Jichi Medical ...
TASS/. Post-registration trials of a vaccine against the coronavirus developed by the Vector State Research Center of Virology and Biotechnology will begin in November-December, the press service ...
Earlier the sanitary watchdog who runs the Vector center reported that 86 volunteers would receive the vaccine during the second phase of clinical trials. Russia, like any other country ...
An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide ... completed a Phase III clinical trial of their intramuscular COVID-19 vaccine, which involved 45,000 ...
the phase 1/2 study and another phase 3 trial of Zynteglo in SCD have been suspended as the company investigates whether the cancers could be related to the BB305 lentiviral vector used in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results